A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients
Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
This study will investigate the effects of a potential neuroprotectant compound, YM872, in
the treatment of acute ischemic stroke. The study will determine if a 24-hour infusion of
YM872, given within 6 hours of stroke onset, reduces the ischemic lesion volume as measured
by MRI at 28 days after the infusion is given. The clinical effects of YM872 will also be
determined by neurological function and disability scores at follow up visits through Day 90
of the study.